Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AA31	AUBAGIO	B	Teriflunomide - 14mg	14mg	Tablet, film coated	38,773,533 L.L
R05CA	ASPECTON COUGH SYRUP	G	Thyme soft extract - 6.69g/100ml		Syrup	588,603 L.L
B01AC17	AGGRASTAT	B	Tirofiban hydrochloride monohydrate - 0.25mg/ml	0.25mg/ml	Injectable concentrated solution	18,280,324 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 162mg/0.9ml	162mg/0.9ml	Injectable solution	79,959,812 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 200mg/10ml	200mg/10ml	Injectable concentrated solution	25,485,937 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	47,925,322 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 80mg/4ml	80mg/4ml	Injectable concentrated solution	11,127,864 L.L
L01FD01	ARYOTRUST	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	21,176,745 L.L
L01FD01	ARYOTRUST	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution + solvent	34,948,930 L.L
D10AD01	A-RET	G	Tretinoin - 0.05%	0.05%	Cream	335,961 L.L
D10AD01	AVOTIN-A	G	Tretinoin - 0.05%	0.05%	Cream	440,780 L.L
D10AD06	AKLIEF	B	Trifarotene - 50mcg/g	50mcg/g	Cream	4,359,425 L.L
C09CA03	ANGINET	G	Valsartan - 160mg	160mg	Tablet, film coated	544,256 L.L
C09CA03	ARBITEN 160	G	Valsartan - 160mg	160mg	Tablet	544,256 L.L
C09DX01	ARBITEN AM PLUS	G	Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg		Tablet	857,372 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg		Tablet	544,256 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 25mg		Tablet	579,196 L.L
C09DX01	ANGIOSAR PLUS	G	Valsartan - 320mg, Amlodipine - 10mg, Hydrochlorothiazide - 25mg		Tablet, film coated	1,689,210 L.L
C09CA03	ANGINET	G	Valsartan - 80mg	80mg	Tablet, film coated	387,027 L.L
C09CA03	ARBITEN 80	G	Valsartan - 80mg	80mg	Tablet	387,027 L.L
R03AL03	ANORO ELLIPTA	B	Vilanterol - 25mcg, Umeclidinium bromide - 62.5mcg		Inhalation powder	5,367,774 L.L
A11CC05	ALTO D 10.000	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	895,895 L.L
A11CC05	ALTUM-D3	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	561,342 L.L
A11CC05	ALTUM	G	Vitamin D3 - 50,000IU	50,000IU	Capsule, hard	712,620 L.L
V07AB01	ARWAN WFI	G	Water for injection -		Water for injection, irrigation	399,915 L.L
M05BA08	ACLASTA	B	Zoledronic acid (monohydrate) - 5mg/100ml	5mg/100ml	Injectable solution	21,075,062 L.L

...